Curing ALS and Alzheimer’s with AI featuring Alice Zhang @ ETL

February 20, 2019 | 4:30pm - 5:20pm | NVIDIA Auditorium, Huang Engineering Center

Join us for a conversation with Alice Zhang, co-founder and CEO of Verge Genomics. Verge Genomics uses artificial intelligence and human genomics to transform drug discovery for multiple diseases beginning with ALS, Parkinson’s Disease, and Alzheimer’s Disease. Zhang has driven systems biology research at the National Cancer Institute, the Lewis-Sigler Institute for Integrative Genomics at Princeton University and UCLA.

Zhang graduated from Princeton University with high honors in Molecular Biology.

The Entrepreneurial Thought Leaders Series is supported by the venture capital firm DFJ.

Full event information:

Contact Email: